Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair.

Slides:

Advertisements

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:

Advertisements

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Journal of Vascular Surgery

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Without prejudice Journal of Vascular Surgery

Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease Yiu Che Chan, MBBS, MD, FRCS, Stephen.

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy Rubie Sue Jackson, MD, MPH, James.

Michael H. Criqui, MD, MPH, Lindsey A. Ho, MPH, Julie O

Contemporary outcomes after superficial femoral artery angioplasty and stenting: The influence of TASC classification and runoff score Daniel M. Ihnat,

Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions Wei Ye, MD, Chang-Wei Liu,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Revision using distal inflow is a safe and effective treatment for ischemic steal syndrome and pathologic high flow after access creation Thomas M. Loh,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Mortality variability after endovascular versus open abdominal aortic aneurysm repair in a large tertiary vascular center using a Medicare-derived risk.

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele.

Without prejudice Journal of Vascular Surgery

Collateral artery from arteriovenous malformation of the rectum in a patient with peripheral artery disease Hirotomo Uchiyama, MD, Reiji Hattori, MD,

Michael S. Conte, MD Journal of Vascular Surgery

Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral-popliteal bypass in the.

Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery Toshifumi Kudo, MD, PhD,

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Poststent ballooning is associated with increased periprocedural stroke and death rate in carotid artery stenting Tammam Obeid, MBBS, Dean J. Arnaoutakis,

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease Jean-Baptiste Ricco,

Derek de Grijs, MD, Pedro Teixeira, MD, Steven Katz, MD

Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia Christopher.

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J

Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access Isibor Arhuidese, MD, MPH, Thomas Reifsnyder,

Susanna L. Matsen, MD, David C. Chang, PhD, MPH, MBA, Bruce A

Caitlin W. Hicks, MD, MS, Joseph K

Benign superior vena cava syndrome: Stenting is now the first line of treatment Adnan Z. Rizvi, MD, Manju Kalra, MBBS, Haraldur Bjarnason, MD, Thomas.

Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Performance of the Aorfix endograft in severely angulated proximal necks in the PYTHAGORAS United States clinical trial Mahmoud B. Malas, MD, MHS, William.

Thomas E. Brothers, MD, Jacob G. Robison, MD, Bruce M. Elliott, MD

Development of a duplex-derived velocity risk prediction model of disease progression in patients with moderate asymptomatic carotid artery stenosis

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Primary stenting of the superficial femoral and popliteal artery

Balloon angioplasty for revision of failing lower extremity bypass grafts Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Ilia Gur, MD, William Lee, MD, Gabriel Akopian, MD, Vincent L

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease Robert W. Chang, MD, Philip P. Goodney,

Endarterectomy versus stenting in patients with prior ipsilateral carotid artery stenting Isibor J. Arhuidese, MD, MPH, Besma Nejim, MD, MPH, Susruth.

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: Long-term results Jean-Paul P.M. de Vries,

Eric C. Scott, MD, Andre Biuckians, MD, MPH, Ryan E

Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia W. Brent Keeling, MD, Murray L. Shames,

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

Charles S. Joels, MD, John W. York, MD, Corey A. Kalbaugh, MS, David L

Society for Vascular Surgery Vascular Registry evaluation of stent cell design on carotid artery stenting outcomes Jeffrey Jim, MD, Brian G. Rubin, MD,

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Long-Term Outcomes of an Endovascular-First Approach for Diabetic Patients With Predominantly Tibial Disease Caitlin W. Hicks, MD, MS, Joseph K. Canner,

Efficacy of axillary-to-femoral vein bypass in relieving venous hypertension in dialysis patients with symptomatic central vein occlusion Joshua C. Grimm,

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Impact of Dual Antiplatelet Therapy on Superficial Femoral Artery Stent Patency in the Vascular Study Group of New England Ryan M. Svoboda, Karina A.

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease—Decision analysis Brian Nolan, MD,

Determinants of successful peroneal artery bypass

Endovascular interventions for TASC II D femoropopliteal lesions

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses Caitlin W. Hicks, MD, MS,

Iliac artery stenting versus surgical reconstruction for TASC (transatlantic inter-society consensus) type B and type C iliac lesions Carlos H Timaran,

Caitlin W. Hicks, Joseph K

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Comparison of surgical bypass with angioplasty and stenting of superficial femoral artery disease Mahmoud B. Malas, MD, MHS, Ngozi Enwerem, MBBS, Umair Qazi, MD, MPH, Brendan Brown, MPH, Eric B. Schneider, PhD, Thomas Reifsnyder, MD, Julie A. Freischlag, MD, Bruce A. Perler, MD Journal of Vascular Surgery Volume 59, Issue 1, Pages 129-135 (January 2014) DOI: 10.1016/j.jvs.2013.05.100 Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 1 Primary patency in the stent group compared with the bypass group. Journal of Vascular Surgery 2014 59, 129-135DOI: (10.1016/j.jvs.2013.05.100) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 2 Primary-assisted patency in the stent group compared with the bypass group. Journal of Vascular Surgery 2014 59, 129-135DOI: (10.1016/j.jvs.2013.05.100) Copyright © 2014 Society for Vascular Surgery Terms and Conditions

Fig 3 Primary patency for all patients (stent vs bypass), adjusted for TransAtlantic Inter-Society Consensus (TASC) II lesion type. Journal of Vascular Surgery 2014 59, 129-135DOI: (10.1016/j.jvs.2013.05.100) Copyright © 2014 Society for Vascular Surgery Terms and Conditions